Type-2 Diabetes Case Study

Stephen G. Perry

Description

In 2018 I was diagnosed a type-2 Diabetic. I got out a bound notebook and began documenting my situation. My past glucose was above the glucose normal range of 74-100 mg/dL, my HbA1C 11.5%, my weight was 185 lbs. and my height 5 feet 11.5 ins. I was already using Dr Amy LEE‘s, probiotic BIO-X4. Dr, Lee is a Nutritionist and Weight Management Specialist. A side benefit of her program was my HbA1C dropped to as low as 3.5%. I was monitoring my finger-stick blood glucose levels preBREAKFAST, preLUNCH and preDINNER. On February 15th I started with Dr Marlene Merritt’s Blood Glucose Formula (BGF) to see if this probiotic would indeed lower my circulating blood glucose. The preLUNCH and preDINNER began to separate from the preBREAKFAST (nocturnal) glucose values. This glucose change was statistically significant and the preDINNER glucose levels separated statistically faster led me to identify a nocturnal phase and a diurnal phase of Diabetes. I was able to verify and extend the finger-stick data with the LibreLink technology. Now this single Type-2 Case Study needs to be verified with ten (5 female/5 male) patients and extended to nondiabetics and severe diabetic groups for comparison, and a better understanding of Diabetes. Glucose is a universal energy molecule that can be found in every cell in the body, and maintaining its normal levels is critical to good health. 

Sujets

• Santé et bien-être
• Diététique
• Santé du quotidien
• Santé au quotidien
• Santé au quotidien
• Macrobiotics
• Diet
• Health
• Fitness
• Nutrition
• diététique

Informations

• Publié par: Outskirts Press
• Date de parution: 27 février 2023
• Nombre de lectures: 0
• EAN13: 9781977263643
• Langue: English
• Poids de l'ouvrage: 8 Mo

Extrait

Type-2 Diabetes Case Study All Rights Reserved. Copyright © 2023 Stephen G. Perry Ph.D. v1.0

The opinions expressed in this manuscript are solely the opinions of the author and do not represent the opinions or thoughts of the publisher. The author has represented and warranted full ownership and/or legal right to publish all the materials in this book.

This book may not be reproduced, transmitted, or stored in whole or in part by any means, including graphic, electronic, or mechanical without the express written consent of the publisher except in the case of brief quotations embodied in critical articles and reviews.

Outskirts Press, Inc. http://www.outskirtspress.com

ISBN: 978-1-9772-6364-3

Cover Photo © 2023 Stephen G. Perry Ph.D. All rights reserved - used with permission.

Outskirts Press and the “OP” logo are trademarks belonging to Outskirts Press, Inc.

PRINTED IN THE UNITED STATES OF AMERICA

TABLE OF CONTENTS

TYPE-2 DIABETES CASE STUDY

REFERENCE’S

RESUME

TYPE-2 DIABETES CASE STUDY

STEPHEN G PERRY Ph.D.

STAFF ROBERT R PERRY M.D., MEDICAL DIRECTOR

BRANT P PERRY Ed.D. OPERATIONS DIRECTOR

SHAWN S PERRY Ed.D., TECHNICAL DIRECTOR

KRISTEN N PERRY Ph.D., ADMINISTRATION

SARAH PERRY Ed.M., COUNCILOR

TYPE-2 DIABETES CASE STUDY

DEDICATION: Diane Claire Perry, R.N.

Silvis Memorial Hospital, Silvis, Illinois

Lost her life to sever Diabetes

Introduction:This Case Study details an approach to manage my medical records after being diagnosed as a Type-2 Diabetic.The primary clinical symptoms were high blood glucose (mg/dL) values and a high hemoglobin A1C. Lantus (insulin medication) was prescribed to bring my glucose to the “normal” range. My diet was managed for food allergies and my glucose intake, natural or as an a dded sweetener. I was already reading food labels for sodium as I was being treated for m oderately high blood pressure. Nutritionists identify good and bad foods based on mineral, vitamin, and nutritional content. I learned that “foods” that you have a food allergy (sensitivities) to (Ulett G.A. and S.G Perry, 1974; 1975) are not necessarily good. Therefore, my diet management includes only foods that I have been tested negativ e for, eliminates foods that I have been tested positive for (chocolate, peanut, chicke n, coffee, black tea, corn, oat, potato, etc.), and eliminates foods that I have not been tested for. Additionally, I am taking Dr. Amy Lee’s (www.nucific.com) Probiotic BIO-X4, which balances good and “evil” bacteria in the G.I. tract, and according to Dr. Lee, a happy viscera (pancreas/beta cells) makes for a happy body. She is a Nutritionist and a Weight Management Specialist. I benefited from bowel and urinary regularity in days, signific ant weight loss from 185 pounds to 155 pounds beginning in months, A1C of 11% to as low as 5.3%, 20 units LANTUS am/pm, to 10 units, am/pm, to 5 units am/pm, to 5 units pm, to 0 units (GENETIC INSULIN ???). Insulin is a small double chain peptide hormone tha t is involved in insulin, phosphorylation, and transit of glucose through a c hannel in cell’s plasma membrane, thus lowering circulating glucose and providing a u niversal phosphorylated glucose energy molecule via the Pentose Phosphate Metabolic Pathway to cellular metabolism, and supporting proliferation, differentiation, and growth. Prediabetes is >100-125mg/dL (MLO,www.cir-online.com), and my glucose values were ~130 mg/dL level when the

BLOODSUGARFORMULA(BSF) (www.purehealthresearch.com) was introduced February 15, 2020 into my Treatment Plan. A continuation of the initial study is a solitary Type-2 case study that will require conformational studies , control groups (diabetes-free and severe diabetes), and extended studies.

Method: For most, their Family Practice Physician’s requires several clinical chemistry profiles per year, depending on medical circumstanc es. I was already taking Dr. Amy Lee’s (www.nucific.com). Probiotic (BIO-X4), which requires a capsule with a cup of water before each meal, so I monitored my glucose with a finger stick glucose test premeal three times a day while strictly managing my known food allergy profile (Ulett, G.A. and S.G. Perry, 1974; 1975). I also kept records in a bound research notebook, including what foods were consumed in addition to the blood p ressures that my cardiologist was managing. My food allergy studies revealed an in vivo confirmation of the in vitro Cytotoxic Test (Figure 01.00). Positive allergens (sensitizers) triggered a leukocytosis, and negatives showed no WBC increase over the zero-time control. The leukocytosis was biphasic, with real-time scientific controls ma tching zero-time control values during 3 the 5-hour test.(MLO,The WBC normal range of 4.5-11+ 103/mm www.cir- 3 online.com) would be more like ~4.0-7.5 103/mm if fasting were required. Results are interpreted using the wrong normal range.What happens between 7.5 and 11 3 103/mm ? Leukocytosis (a white cell increase includes the immune system and plasma white cells) and immune-system activity, good, bad, or indifferent, are possible! Plasma white cell recognize protein antigens in phase–1, a nd in phase-2 generate monoclonal antibodies some of which can be autoimmune, and as some have suggested as a possible fate of thebetacells in Type-1 Diabetes.

FIGURE 01.00In vivo Leukocytosistriggered by Cytotoxic Test positive sensitizing foods (Ulett, G.A. and S.G. Perry, 1974; 1975), as a percent of zero-time control WBCs (overnight fasting).The positive in vivo WBC increase is a confirmation of the Cytotoxic Test.The WBC increase was biphasic (interesting!). Test-negative foods showed no leukocytosis. The real-time controls matched the zero-time control, and when leukocytosis maximum value fell back to the real-time control levels at about 4.5 hours, WBC averages +/- 2 S.D.do not overlap documenting the that the WBC values are statistically significantly different at the 95% confidence level (Lowry, O.H. and Passonneau, 1972) for these 10 individuals (5 male/5 female of diverse ages)

Results: The Probiotics BIO-X4 ( www.nucific.com) and Lantus were used while

monitoring systemic glucose (mg/dL) to indirectly a ssess Pancreaticbeta cellsinsulin production in response to treatments to determine d iagnostic metabolic patterns relating to Type-2 Diabetes. Before each meal, finger -stick glucose (mg/dL) was assayed and recorded in a bound researched notebook for each mo nth.

The Case Study results follow. Two tables (July and August 2019) were added to the documentation of the glucose levels during Lantus/BIO-X4 Treatment Plan. The Lantus effect on declining glucose levels was unexpected, whether due to insulin resistance, suppression or deregulation. By discontinuing Lantus, I hoped “exogenous insulin” has been deregulating denovo insulin production in the pancreaticbetacells and will result in a “genetic insulin” kicking in. There is copious data to analyze according to your interest.

NOTES:* Labels Lower Range, **Labels Higher Range St. Dev (SD Is Range/Square Root of (n) (Lowry, O.H. and J.V. Passonneau, 1972). %Variation <_2025_ _acceptable2c_=""><_1525_ _good2c_=""><_1025_ _exceptional2c_="" at="" the="" _9525_="" confidence="">

NOTES:* Labels Lower Range, **Labels Higher Range. St. Dev (SD Is Range/Square Root of (n) (Lowry, O.H. and J.V. Passonneau, 1972). %Variation <_2025_ _acceptable2c_=""><_1525_ _good2c_=""><_1025_ _exceptional2c_="" at="" the="" _9525_="" confidence="">